论文部分内容阅读
网上流行的“恶搞”行为居然传染到了药品采购领域。在广东省药品网上阳光采购价格谈判中,某药企100片一瓶的维C银翘片,企业给出的网上报价竟然高达99999元一片。经过四拨专家轮流上阵砍了四轮,最终专家建议价定为0.053元一片。这一戏剧性的一幕被媒体评价为药企“恶搞”。在公开透明的采购方式下,国内药企被迫降价,固然值得民众欣喜。然而,药企恶搞药价的举动背后,其心态却绝非“恶搞”那么简单:药企要想在竞争中胜出就必须报出低价,但随之而来的却是入不敷出的经营亏损;如果想以高品质的新药博得市场青睐,
Popular online “spoof ” Act actually spread to the field of drug procurement. In Guangdong Province, online drug purchase price negotiations, a pharmaceutical company 100 bottles of Victoria C Yinqiao tablets, online quotes given by enterprises even up to 99999 yuan a. After four dial experts took turns fighting cut four rounds, the final expert suggested price set at 0.053 yuan a. This dramatic scene by the media as pharmaceutical companies “spoof ”. In an open and transparent way of procurement, the domestic pharmaceutical companies forced to cut prices, of course, deserve public joy. However, the behavior of drug companies to spoof drug prices behind their attitude is not “spoof ” so simple: pharmaceutical companies in order to win the competition must be reported low, but then come in is beyond the reach of the business Loss; if you want high-quality new drugs win the favor of the market,